Hybrid Conferencee

International Conference on Antiviral Strategies, Vaccines and Immunology (ICAVSI - 26)

15th - 16th December 2026 | Miami, USA

10% DISCOUNT

Maximum discount capped at $30. Activate your Scholarly Discount during the payment phase to lower your final checkout amount.

REVEAL OFFER
EARLY10
Sample Abstract
Download
Conference Brochure
Sample Full Paper
Download
Conference Notifications:

"Be sure to check this section regularly for all Research Plus International Conference updates. We’ll keep you informed about deadlines, event details, and more important notifications."

Call for Papers Extended:
"The deadline for full paper submissions has been extended for the Research Plus International Conference in Miami. Submit your research by today to participate in one of the top conferences."
Certificate of Presentation:
"Present your research and receive a Certificate of Presentation to recognise your valuable contribution to the conference."
Abstract Submissions Open:
"Abstract submissions for the Miami event are now open! Don’t miss the chance to present your research. Submit now."
Networking with Global Experts:
"Engage with researchers and professionals from around the world at the Miami conference. Build collaborations and gain insights from leading experts."
Keynote Speaker Sessions:
"Don’t miss our Keynote Sessions in Miami, featuring global leaders and innovators sharing their knowledge."
Best Paper & Best Paper Presentation Award:
"Submit your paper and stand a chance to win the Best Paper Presentation Award. The winner will be recognized at the conference in Miami."
SDG-Inspired Conference Focus:
"Our conference will highlight research that addresses global sustainability, inclusive education, and solutions for environmental challenges."

Conference Session Tracks

SDG Wheel

Aligned with

UN Sustainable Development Goals

This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals. It fosters knowledge exchange, innovation, and collaborative engagement.

SDG 3
SDG 3 Good Health and Well-being
SDG 4
SDG 4 Quality Education
SDG 9
SDG 9 Industry, Innovation and Infrastructure
Track 01

Advancements in Antiviral Strategies

This track focuses on the latest developments in antiviral therapies and strategies aimed at combating viral infections. Researchers are invited to present innovative approaches and novel compounds that demonstrate efficacy against a range of viruses.

Track 02

Innovations in Vaccine Development

This session will explore cutting-edge technologies and methodologies in vaccine design and production. Topics may include mRNA vaccines, vector-based vaccines, and novel adjuvants that enhance immune responses.

Track 03

Immunological Responses to Viral Infections

This track examines the immune mechanisms activated during viral infections and their implications for disease progression. Presentations will cover cellular and humoral responses, as well as the role of immune evasion by viruses.

Track 04

Viral Pathogenesis and Disease Mechanisms

This session focuses on the molecular and cellular mechanisms underlying viral pathogenesis. Researchers are encouraged to discuss the interplay between viral factors and host responses that contribute to disease severity.

Track 05

Epidemiology of Infectious Diseases

This track addresses the epidemiological trends and patterns of infectious diseases globally. Presentations will highlight surveillance data, outbreak investigations, and the impact of social determinants on disease spread.

Track 06

Clinical Research in Antiviral Therapies

This session invites discussions on clinical trials and studies evaluating the safety and efficacy of antiviral treatments. Researchers will share insights on patient outcomes and challenges faced in clinical settings.

Track 07

Public Health Strategies for Outbreak Control

This track focuses on public health interventions and strategies aimed at controlling viral outbreaks. Topics may include vaccination campaigns, contact tracing, and community engagement in outbreak response.

Track 08

Immunotherapy Approaches in Infectious Diseases

This session explores the application of immunotherapy in treating viral infections and enhancing host immunity. Presentations will cover monoclonal antibodies, immune checkpoint inhibitors, and therapeutic vaccines.

Track 09

Vaccine Safety and Efficacy Studies

This track will delve into the assessment of vaccine safety profiles and their effectiveness in diverse populations. Researchers are encouraged to present findings from post-marketing surveillance and real-world studies.

Track 10

Emerging Viral Threats and Preparedness

This session addresses the challenges posed by emerging and re-emerging viral pathogens. Discussions will focus on preparedness strategies, rapid response frameworks, and lessons learned from recent outbreaks.

Track 11

Global Collaboration in Infectious Disease Research

This track emphasizes the importance of international collaboration in addressing infectious diseases. Presentations will highlight successful partnerships, data sharing initiatives, and the role of global health organizations.